FLGT - Fulgent Genetics Inc. (FLGT) CEO Ming Hsieh on Q4 2021 Results - Earnings Call Transcript
Fulgent Genetics, Inc. (FLGT) Q4 2021 Earnings Conference Call February 23, 2022 04:30 PM ET Company Participants Nicole Borsje - Investor Relations Ming Hsieh - Chief Executive Officer Brandon Perthuis - Chief Commercial Officer Paul Kim - Chief Financial Officer Larry Weiss - Chief Medical Officer Conference Call Participants Kevin DeGeeter - Oppenheimer. Sung Ji Nam - BTIG David Westenberg - Piper Sandler Presentation Operator Good day and welcome to the Fourth Quarter 2021 Fulgent Genetics Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Nicole Borsje with Investor Relations. Please go ahead. Nicole Borsje Thank you. Good afternoon and welcome to the Fulgent Genetics, fourth quarter 2021 financial results conference call. On the call today are Ming Hsieh, Chief Executive Officer; Paul Kim, Chief Financial Officer; Dr. Larry Weiss, Chief Medical Officer; and Brandon Perthuis, Chief Commercial Officer.
For further details see:
Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q4 2021 Results - Earnings Call Transcript